Phase I Study of Pyrimethamine in Healthy Japanese and Caucasian Subjects

clinical trial

Phase I Study of Pyrimethamine in Healthy Japanese and Caucasian Subjects is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT03258762

P6099clinical trial phasephase I clinical trialQ5452194
P17countryAustraliaQ408
P582end time2017-11-19
P921main subjecttoxoplasmosisQ154878
P4135maximum age64
P1050medical conditiontoxoplasmosisQ154878
P2899minimum age20
P1132number of participants14
P4844research interventioncalcium oxalateQ412399
leucovorin calciumQ27077063
P6153research siteGSKQ212322
P859sponsorGSKQ212322
P580start time2017-09-25
P8363study typeinterventional studyQ78089383
P1476titleA Single Centre, Open-label, Parallel-group, Single Oral Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Pyrimethamine in Healthy Japanese and Caucasian Male Subjects

Search more.